Cisplatin-Induced Hearing Loss Up for Young Children With Cancer
Cumulative incidence highest in patients aged 5 years and younger; factors that influence development include cumulative dose of cisplatin
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.